|

MDX2003 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • ModeX Therapeutics, An OPKO Health Company1

Indications

  • HGBCL1
  • PMBCL1
  • Waldenström Macroglobulinemia (WM)1
  • FL Lymphoma1
  • Lymphoplasmacytic Lymphoma1

Other1 trial

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.